IL218438A0 - Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof - Google Patents
Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereofInfo
- Publication number
- IL218438A0 IL218438A0 IL218438A IL21843812A IL218438A0 IL 218438 A0 IL218438 A0 IL 218438A0 IL 218438 A IL218438 A IL 218438A IL 21843812 A IL21843812 A IL 21843812A IL 218438 A0 IL218438 A0 IL 218438A0
- Authority
- IL
- Israel
- Prior art keywords
- hsp65
- methods
- humanized antibodies
- antibodies specific
- derived peptide
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL218438A IL218438B (en) | 2009-09-06 | 2012-03-01 | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24021809P | 2009-09-06 | 2009-09-06 | |
PCT/IL2010/000731 WO2011027349A1 (en) | 2009-09-06 | 2010-09-06 | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof |
IL218438A IL218438B (en) | 2009-09-06 | 2012-03-01 | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
IL218438A0 true IL218438A0 (en) | 2012-04-30 |
IL218438B IL218438B (en) | 2019-05-30 |
Family
ID=46145245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL218438A IL218438B (en) | 2009-09-06 | 2012-03-01 | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL218438B (en) |
-
2012
- 2012-03-01 IL IL218438A patent/IL218438B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL218438B (en) | 2019-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1256304A1 (en) | Methods and reagents for creating monoclonal antibodies | |
IL250624B (en) | Anti-fgfr3 antibodies and methods using same | |
ZA201207484B (en) | Humanized anti-egfl7 antibodies and methods using same | |
IL244197A0 (en) | Anti-cd100 antibodies and methods for using the same | |
IL215649A (en) | Anti-tnf-α monoclonal antibodies and uses thereof | |
IL220404A (en) | Humanized antibodies | |
ZA201005348B (en) | Humanized anti-c5ar antibodies | |
EP2540745A4 (en) | Fully humanized anti-her2 antibody, preparation method and use thereof | |
IL215314A0 (en) | Humanized antibodies against light and uses thereof | |
IL217919A0 (en) | Humanized anti-cdcp1 antibodies | |
HK1168871A1 (en) | Monoclonal antibodies | |
SI2510011T1 (en) | Monoclonal antibodies that bind b7h6 and uses thereof | |
EP2742067A4 (en) | Anti-fzd10 monoclonal antibodies and methods for their use | |
EP2593475A4 (en) | Anti-addl monoclonal antibody and uses thereof | |
ZA201202793B (en) | Humanized antibodies against human il-22ra | |
EP2475383A4 (en) | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof | |
IL219136A0 (en) | Anti-hepsin antibodies and methods using same | |
EP2484694A4 (en) | Monoclonal antibody against human hig-1 polypeptide | |
IL218438A0 (en) | Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof | |
EP2540742A4 (en) | Anti-cyr61 protein monoclonal antibodies and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |